Immunomodulatory Effects of Radiofrequency Ablation in a Breast Cancer Model

REFERENCES

• Anderson, K.M., Srivastava, P.K. (2000). Heat, heat shock, heat shock proteins and death: a central link in innate and adaptive immune responses. Immunol. Lett. 74:35–39.
   PubMed Web of Science ®Google Scholar
• Basu, S., Binder, R., Suto, R., Anderson, K., Srivastava, P. K. (2000). Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kB pathway. Int. Immunol. 12:1539.
   PubMed Web of Science ®Google Scholar
• Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., Banham, A. H. (2006). Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J. Clin. Oncol. 24:5373–5380.
   PubMed Web of Science ®Google Scholar
• Bland, K.L., Gass, J., Klimberg, V.S. (2007). Radiofrequency, cryoablation, and other modalities for breast cancer ablation. Surg. Clin. North Am. 87(2):539–550.
   PubMed Web of Science ®Google Scholar
• Ciocca, D.R., Calderwood, S.K. (2005). Heat shock proteins in cancer:diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10(2):86–103.
   PubMed Web of Science ®Google Scholar
• Clark, P. R., Menoret, A. (2001). The inducible Hsp70 as a marker of tumor immunogenicity. Cell Stress Chaperones 6:121–125.
   PubMed Web of Science ®Google Scholar
• Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L., Zou, W. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10:942–949.
   PubMed Web of Science ®Google Scholar
• den Brok, M. H., Sutmuller, R. P., Nierkens, S., Bennink, E.J., Frielink, C., Toonen, L. W., Boerman, O. C., Figdor, C. G., Ruers, T. J., Adema, G. J. (2006). Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br. J. Cancer 95:896–905.
   PubMed Web of Science ®Google Scholar
• Diefenbach, A., Jensen, E. R., Jamieson, A. M., Raulet, D. H. (2001). Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature (Lond.) 413:165–171.
   PubMed Web of Science ®Google Scholar
• Fagnoni, F. F., Ferrari, C., Missale, G. (2006). Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res. 66(2):1139–1146.
   PubMedGoogle Scholar
• Fisher, E. R., Anderson, S., Tan-Chiu, E., Fisher, B., Eaton, L., Wolmark, N. (2001). Fifteen-year prognostic discriminants for invasive breast carcinoma: national surgical adjuvant breast and bowel project protocol-06. Cancer Supplement 91(8):1679–1687.
   Google Scholar
• Fortin, A., Larochelle, M., Laverdière, J., Lavertu, S., Tremblay, D. (1999). Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J. Clin. Oncol. 17(1):101–109.
   PubMedGoogle Scholar
• Goldberg, S. N., Gazelle, G. S., Mueller, P. R. (2000). Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am. J. Roentgenol. 174(2):323–331.
   PubMed Web of Science ®Google Scholar
• Golgher, D., Jones, E., Powrie, F., Elliott, T., Gallimore, A. (2002). Depletion of CD25_ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol. 32:3267–3275.
   PubMed Web of Science ®Google Scholar
• Gonzalez, H. D., Figueras, J. (2007). Effect of surgical resection of metastatic disease on immune tolerance to cancer. How a systemic disease could be controlled by a local therapy. Clin. Transl. Oncol. 9:571.
   PubMedGoogle Scholar
• Grieco, C. A., Simon, C. J., Mayo-Smith, W. W., DiPetrillo, T. A., Ready, N. E., Dupuy, D. E. (2006). Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J. Vasc. Interv. Radiol. 17(7):1117–1124.
   PubMed Web of Science ®Google Scholar
• Hansler, J., Wissniowski, T. T., Schuppan, D., Witte, A., Bernatik, T., Hahn, E. G., Strobel, D. (2006). Activation and dramatically increased cytolytic activity of tumor specifi c T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. World J. Gastroenterol. 12(23):3716–3721.
   PubMed Web of Science ®Google Scholar
• Jaattela, M. (1999). Heat shock proteins as cellular lifeguards. Ann. Med. 31:261–271.
   PubMed Web of Science ®Google Scholar
• Jarnicki, A.G., Lysaght, J., Todryk, S., Mills, K. H. (2006). Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J. Immunol. 177(2):896–904.
   PubMed Web of Science ®Google Scholar
• Jordan, M., Boesteanu, A., Reed, A., Petrone, A., Holenbeck, A., Lerman, M., Naji, A., Caton, A. (2001). Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301–306.
   PubMed Web of Science ®Google Scholar
• Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., Smyth, M. J. (2002). Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3:83–90.
   PubMed Web of Science ®Google Scholar
• Kenderov, A., Minkova, V., Mihailova, D., Giltiay, N., Kyurkchiev, S., Kehayov, I., Kaveri, S., Kazatchkine, M., Pashov, A. (2002). Lupus specific kidney deposits of HSP90 are associated with altered IgG iditypic interactions of anti-HSP90 autoantibodies. Clin. Exp. Immunol. 129:169–176.
   PubMed Web of Science ®Google Scholar
• Kitani, A., Chua, K., Nakamura, K., Strober, W. (2000). Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J. Immunol. 165:691–702.
   PubMedGoogle Scholar
• Klimberg, V. S., Kepple, J., Shafirstein, G., Adkins, L., Henry-Tillman, R., Youssef, E., Brito, J., Talley, L., Korourian, S. (2006). eRFA: Excision followed by RFA—A new technique to improve local control in breast cancer. Ann. Surg. Oncol. 13(11):1422–1433.
   PubMed Web of Science ®Google Scholar
• Kobayashi, N., Hiraoka, N., Yamagami, W., Ojima, H., Kanai, Y., Kosuge, T., Nakajima, A., Hirohashi, S. (2007). FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin. Cancer Res. 13:902–911.
   PubMed Web of Science ®Google Scholar
• Li, Z. (1997). Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines. Semin. Immunol. 9:315–322.
   PubMedGoogle Scholar
• Li, Z. (2001). The roles of heat shock proteins in tumor immunity. Cancer. Chemother. Biol. Response Modif. 19:371–383.
   PubMedGoogle Scholar
• Lindquist, S., Craig, E. A. (1988). The heat shock proteins. Ann. Rev. Genetics 22:631–677.
   PubMed Web of Science ®Google Scholar
• Liyanage, U. K., Moore, T. T., Joo, H. G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., Linehan, D. C. (2002). Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169:2756–2761.
   PubMed Web of Science ®Google Scholar
• MacConmara, M. P., Maung, A. A., Fujimi, S., McKenna, A. M., Delisle, A., Lapchak, P. H., Rogers, S., Lederer, J. A., Mannick, J. A. (2006). Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann. Surg. 244:514–523.
   PubMedGoogle Scholar
• Manzo, G. (1998). Natural killer cell reactivity: activation and cytolysis mechanism models, involving heat shock protein, haemopoietic histocompatibility, major histocompatibility complex and complement molecules. Med. Hypotheses 51:5–9.
   PubMedGoogle Scholar
• Massa, C., Guiducci, C., Arioli, I., Parenza, M., Colombo, M. P., Melani, C. (2004). Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70. Cancer Res. 64:1502–1508.
   PubMed Web of Science ®Google Scholar
• Matsuura, K. Y., Yamaguchi, H., Ueno, A., Osaki, K., Arihiro, K., Toge, T. (2006). Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma. Cancer 106:1227.
   PubMed Web of Science ®Google Scholar
• Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., Vile, R. G. (1998). Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 4:581–587.
   PubMed Web of Science ®Google Scholar
• Menoret, A., Patry, Y., Burg, C., Le Pendu, J. (1995). Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas. J. Immunol. 155:740–747.
   PubMed Web of Science ®Google Scholar
• Morimoto, R. I., Santoro, M. G. (1998). Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat. Biotechnol. 16:833–838.
   PubMed Web of Science ®Google Scholar
• Multoff, G. (2002). Activation of natural killer cells by heat shock protein 70. Int J. Hyperthermia 18(6):576–585.
   PubMedGoogle Scholar
• Multhof, G., Pfister, K., Gehrmann, M., Hantschel, M., Gross, C., Hafner, M., Hiddemann, W. (2001). A 14-mer Hsp70 peptide stimulates NK cell activity. Cell Stress Chaperones 6:337–344.
   PubMedGoogle Scholar
• Ni Choileain, N. M., MacConmara, Y., Zang, T. J., Murphy, J. A., Mannick, J., Lederer, J. A. (2006). Enhanced regulatory T cell activity is an element of the host response to injury. J. Immunol. 176:225–236.
   PubMedGoogle Scholar
• Nielsen, C. H., Leslie, R. G., Jepsen, B. S., Kazatchkine, M. D., Kaveri, S. V., Fischer, E. (2001). Natural autoantibodies and complement promote the uptake of a self antigen, human thyroglobulin, by B cells and the proliferation of thyroglobulin-reactive CD4(+) T cells in healthy individuals. Eur. J. Immunol. 31:2660–2668.
   PubMed Web of Science ®Google Scholar
• Pashov, A., Kenderov, A., Kyurkchiev, S., Kehayov, I., Hristova, S., Lacroix-Desmazes, S., Giltiay, N., Sooryanarayana, N., Kazatchkine, M. D., Kaveri, S. V. (2002). Autoantibodies to heat shock protein 90 (HSP90) in the human natural antibody repertoire. Int. Immunol. 14:453–461.
   PubMedGoogle Scholar
• Pashov, A., Monzavi-Karbassi, B., Chow, M., Cannon, M., Kieber-Emmons, T. (2007). Immune surveillance as a rationale for immunotherapy?. Hum. Vaccine 3:224–228.
   PubMed Web of Science ®Google Scholar
• Peng, P., Ménoret, A., Srivastava, P. K. (1997). Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography. J. Immunol. Meth. 204:13–21.
   PubMedGoogle Scholar
• Polak, M. E., Borthwick, N. J., Gabriel, F. G., Johnson, P., Higgins, B., Hurren, J., McCormick, D., Jager, M. J., Cree, I. A. (2007). Mechanisms of local immunosuppression in cutaneous melanoma. Br. J. Cancer 96:1879.
   PubMed Web of Science ®Google Scholar
• Rossi, S., Buscarini, E., Garbagnati, F., (1998). Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol 170:1015–1022.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, S. (2003). The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. J. Clin. Invest. 112:1310–1312.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, S. (2004). Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531–562.
   PubMed Web of Science ®Google Scholar
• Sasada, T. M., Kimura, Y., Yoshida, M., Kanai, M., Takabayashi, A. (2003). CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98:1089.
   PubMed Web of Science ®Google Scholar
• Schhuller, G., Kettenbach, J., Sedivy, R., Stift, A., Friedl, J., Gnant, M., Lammer, J. (2004). Heat shock protein expression induced by percutaneous radiofrequency ablation of hepatocellular carcinoma in vivo. Inter. J. Oncol. 24:609–613.
   PubMedGoogle Scholar
• Shevach, E. M. (2002). CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol 2:389.
   PubMed Web of Science ®Google Scholar
• Shinnick, T. M. (1991). Heat shock proteins as antigens of bacterial and parasitic pathogens. Curr. Top. Microbiol. Immunol. 167:145–160.
   PubMed Web of Science ®Google Scholar
• Singletary, E. S. (2002). Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Amer. J. Surg. 184:383–393.
   PubMed Web of Science ®Google Scholar
• Srivastava, P. K. (2005). Immunotherapy for human cancer using heat shock protein-peptide complexes. Curr. Oncol. Rep. 7(2):104–108.
   PubMedGoogle Scholar
• Srivastava, P. K., Udono, H. (1994). Heat shock protein-peptide complexes in cancer immunotherapy. Curr. Opin. Immunol. 6:728–732.
   PubMed Web of Science ®Google Scholar
• Todryk, S., Melcher, A., Hardwick, N., Linardakis, E., Bateman, A., Colombo, M.P., (1999). Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. 163:1398.
   PubMed Web of Science ®Google Scholar
• Tokuno, K., Hazama, S., Yoshino, S., Yoshida, S., Oka, M. (2009). Increased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancer. Anticancer Res. 29:1527–1532.
   PubMed Web of Science ®Google Scholar
• Udono, H., Srivastava, P. K. (1993). Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178:1391–1395.
   PubMed Web of Science ®Google Scholar
• Vieweg, J., Su, Z., Dahm, P., Kusmartsev, S. (2007). Reversal of tumor-mediated immunosuppression. Clin. Cancer Res. 13(2 Pt 2):727s–732s.
   PubMed Web of Science ®Google Scholar
• Viguier, M. F., Lemaitre, O., Verola, M. S., Cho, G., Gorochov, L., Dubertret, H., Bachelez, P., Kourilsky, P., Ferradini, L. (2004). Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 173:1444.
   PubMed Web of Science ®Google Scholar
• Welch, W. J. (1992). Mammalian stress response: cell physiology, structure/ function of stress proteins, and implications of medicine and disease. Physiolog. Rev. 172(4):1063–1081.
   Google Scholar
• Wolf, A. M., Wolf, D., Steurer, M., Gastl, G., Gunsilius, E., Grubeck-Loebenstein, B. (2003). Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. 9:606.
   PubMed Web of Science ®Google Scholar
• Woo, E. Y., Chu, C. S., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., June, C. H. (2001). Regulatory CD4_CD25_ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61:4766–4772.
   PubMed Web of Science ®Google Scholar
• Wu, F., Wang, Z. B., Lu, P., Xu, Z. L., Chen, W. Z., Zhu, H., Jin, C. B. (2004). Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med. Biol. 30:1217–1222.
   PubMed Web of Science ®Google Scholar
• Zerbini, A., Pilli, M., Penna, A., Pelosi, G., Schianchi, C., Molinari, A., Schivazappa, S., Zibera, C., Zhu, X., Zhao, X., Burkholder, W. F., Gragerov, A., Ogata, C. M., Gottesman, M. E., Hendrickson, W. A. (1996). Structural analysis of substrate binding of the molecular chaperone DnaK. Science 272:1606–1614.
   PubMedGoogle Scholar
• Zhu, X., Zhao, X., Burkholder, W. F., Gragerov, A., Ogata, C. M., Gottesman, M. E., Hendrickson, W. A. (1996). Structural analysis of substrate binding by the molecular chaperone Dnak. Science 272:1606–1614.
   PubMed Web of Science ®Google Scholar
• Zlotta, A. R., Wildschutz, T., Raviv, G., (1997). Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J. Endourol. 11:251–258.
   PubMed Web of Science ®Google Scholar